Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Must Lay Out Remediation Specifics To Regain Trust In OTCs – Expert

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare continues on the long road back to full manufacturing strength and consumer confidence in its OTCs with an ongoing review of issues that have plagued the company with recalls.
Advertisement

Related Content

FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
McNeil OTC Recalls Slice $900M From J&J's 2010 Sales
McNeil OTC Recalls Slice $900M From J&J's 2010 Sales
McNeil OTC Recalls Slice $900M From J&J's 2010 Sales
Rolaids Recall Puts Contract Manufacturers In Issa's Crosshairs
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
J&J Submits McNeil Plant Reforms To FDA, Announces Layoffs

Topics

Advertisement
UsernamePublicRestriction

Register

PS104814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel